
- ONCOLOGY Vol 12 No 1
- Volume 12
- Issue 1
Simpler, Less Expensive Test for Ulcer Bug
Researchers from the University of Wurzburg in Germany have determined that a simple antibody test may be as effective in detecting Helicobacter pylori infection as the more invasive procedures that are currently used. They reported their findings
Researchers from the University of Wurzburg in Germany have determined that a simple antibody test may be as effective in detecting Helicobacter pylori infection as the more invasive procedures that are currently used. They reported their findings in the December 1997 issue of the Journal of Clinical Microbiology.
In the study, the researchers compared the sensitivity of a test for Hpylori-specific immunoglobulin G (IgG) antibodies with the standard tests in clinical practice. The antibody test had a 98% sensitivity, correctly diagnosing 58 of the 59 patients diagnosed by standard methods.
The current gold standard tests in clinical practice, endoscopy for histology and the rapid urease test, are limited by their relatively high costs and the need for invasive procedures, say the researchers. Determination of antibodies against H pylori presents a relatively simple diagnostic method, with kits that can be used to perform this method now...readily available from commercial sources.
Helicobacter pylori is a bacterium that lives in the harsh acidic environment of the stomach. The cause of most duodenal ulcers and an estimated 70% to 80% of gastric ulcers, H pylori is considered to be a risk factor for stomach cancer.
Articles in this issue
about 28 years ago
Small-Cell Lung Cancer: Is There a Standard Therapy?about 28 years ago
Recent Advances With Chemotherapy for NSCLC: The ECOG Experienceabout 28 years ago
Overcoming Drug Resistance in Lung Cancerabout 28 years ago
Paclitaxel/Carboplatin in the Treatment of Non-Small-Cell Lung Cancerabout 28 years ago
The Role of Carboplatin in the Treatment of Small-Cell Lung CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
































































































